• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症治疗中的生物聚合物纳米载体:释放生物活性抗癌化合物的潜力以增强药物递送

Biopolymeric nanocarriers in cancer therapy: unleashing the potency of bioactive anticancer compounds for enhancing drug delivery.

作者信息

Hadkar Vrushali Manoj, Mohanty Chirasmita, Selvaraj Chinnadurai Immanuel

机构信息

School of Biosciences and Technology, Vellore Institute of Technology (VIT) Vellore 632014 Tamil Nadu India.

Department of Genetics and Plant Breeding, VIT School of Agricultural Sciences and Advanced Learning (VAIAL), VIT Vellore 632014 Tamil Nadu India

出版信息

RSC Adv. 2024 Aug 12;14(35):25149-25173. doi: 10.1039/d4ra03911d.

DOI:10.1039/d4ra03911d
PMID:39139249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11317881/
Abstract

Effective cancer treatment is becoming a global concern, and recent developments in nanomedicine are essential for its treatment. Cancer is a severe metabolic syndrome that affects the human population and is a significant contributing factor to deaths globally. In science, nanotechnology offers rapidly developing delivery methods for natural bioactive compounds that are becoming increasingly prominent and can be used to treat diseases in a site-specific way. Chemotherapy and radiotherapy are conventional approaches for preventing cancer progression and have adverse effects on the human body. Many chemically synthesized drugs are used as anticancer agents, but they have several side effects; hence, they are less preferred. Medicinal plants and marine microorganisms represent a vast, mostly untapped reservoir of bioactive compounds for cancer treatment. However, they have several limitations, including nonspecific targeting, weak water solubility and limited therapeutic potential. An alternative option is the use of biopolymeric nanocarriers, which can generate effective targeted treatment therapies when conjugated with natural anticancer compounds. The present review focuses on biopolymeric nanocarriers utilizing natural sources as anticancer drugs with improved tumor-targeting efficiency. This review also covers various natural anticancer compounds, the advantages and disadvantages of natural and synthetic anticancer compounds, the problems associated with natural anticancer drugs and the advantages of biopolymeric nanocarriers over synthetic nanocarriers as drug delivery agents. This review also discusses various biopolymeric nanocarriers for enhancing the controlled delivery of anticancer compounds and the future development of nanomedicines for treating cancer.

摘要

有效的癌症治疗正成为全球关注的问题,纳米医学的最新进展对其治疗至关重要。癌症是一种严重的代谢综合征,影响着人类,是全球死亡的一个重要促成因素。在科学领域,纳米技术为天然生物活性化合物提供了快速发展的递送方法,这些化合物正变得越来越突出,并可用于以位点特异性方式治疗疾病。化疗和放疗是预防癌症进展的传统方法,对人体有不良影响。许多化学合成药物被用作抗癌剂,但它们有几种副作用;因此,它们不太受青睐。药用植物和海洋微生物代表了用于癌症治疗的生物活性化合物的巨大、大多未开发的宝库。然而,它们有几个局限性,包括非特异性靶向、水溶性差和治疗潜力有限。另一种选择是使用生物聚合物纳米载体,当与天然抗癌化合物结合时,它们可以产生有效的靶向治疗疗法。本综述重点关注利用天然来源作为抗癌药物的生物聚合物纳米载体,其具有提高的肿瘤靶向效率。本综述还涵盖了各种天然抗癌化合物、天然和合成抗癌化合物的优缺点、与天然抗癌药物相关的问题以及生物聚合物纳米载体作为药物递送剂相对于合成纳米载体的优势。本综述还讨论了用于增强抗癌化合物控释的各种生物聚合物纳米载体以及用于治疗癌症的纳米医学的未来发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/41e14d29dbd2/d4ra03911d-p3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/311a3e6d5f6f/d4ra03911d-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/0eb68cfa4920/d4ra03911d-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/a666b6f26683/d4ra03911d-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/5976d88538ff/d4ra03911d-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/fc5cdd306587/d4ra03911d-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/3bba828621df/d4ra03911d-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/efe3b10a6c22/d4ra03911d-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/3397c6db10ed/d4ra03911d-p1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/f8b1d9d8c72c/d4ra03911d-p2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/41e14d29dbd2/d4ra03911d-p3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/311a3e6d5f6f/d4ra03911d-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/0eb68cfa4920/d4ra03911d-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/a666b6f26683/d4ra03911d-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/5976d88538ff/d4ra03911d-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/fc5cdd306587/d4ra03911d-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/3bba828621df/d4ra03911d-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/efe3b10a6c22/d4ra03911d-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/3397c6db10ed/d4ra03911d-p1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/f8b1d9d8c72c/d4ra03911d-p2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/11317881/41e14d29dbd2/d4ra03911d-p3.jpg

相似文献

1
Biopolymeric nanocarriers in cancer therapy: unleashing the potency of bioactive anticancer compounds for enhancing drug delivery.癌症治疗中的生物聚合物纳米载体:释放生物活性抗癌化合物的潜力以增强药物递送
RSC Adv. 2024 Aug 12;14(35):25149-25173. doi: 10.1039/d4ra03911d.
2
Biopolymeric nanoparticles based effective delivery of bioactive compounds toward the sustainable development of anticancerous therapeutics.基于生物聚合物纳米颗粒的生物活性化合物有效递送促进抗癌治疗的可持续发展。
Front Nutr. 2022 Jul 15;9:963413. doi: 10.3389/fnut.2022.963413. eCollection 2022.
3
Advancement in Biopolymer Assisted Cancer Theranostics.生物聚合物辅助癌症治疗的进展。
ACS Appl Bio Mater. 2023 Oct 16;6(10):3959-3983. doi: 10.1021/acsabm.3c00458. Epub 2023 Sep 12.
4
The development of nanocarriers for natural products.天然产物的纳米载体的发展。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 May-Jun;16(3):e1967. doi: 10.1002/wnan.1967.
5
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.癌症的先进靶向疗法:药物纳米载体,化疗的未来。
Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23.
6
Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs.纳米载体:一种可靠的抗癌药物递送工具。
Pharmaceutics. 2022 Jul 28;14(8):1566. doi: 10.3390/pharmaceutics14081566.
7
Phytocompounds and Nanoformulations for Anticancer Therapy: A Review.植物化合物和纳米制剂在癌症治疗中的应用:综述。
Molecules. 2024 Aug 9;29(16):3784. doi: 10.3390/molecules29163784.
8
Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers.纳米医学作为天然化合物递送以预防和治疗癌症的一种策略。
Curr Pharm Des. 2016;22(27):4219-31. doi: 10.2174/1381612822666160620072539.
9
Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges.基于天然化合物的癌症治疗纳米药物:未来方向与挑战。
Drug Deliv Transl Res. 2024 Oct;14(10):2845-2916. doi: 10.1007/s13346-024-01649-z. Epub 2024 Jul 13.
10
Folic Acid Conjugated Nanocarriers for Efficient Targetability and Promising Anticancer Efficacy for Treatment of Breast Cancer: A Review of Recent Updates.叶酸偶联纳米载体用于提高靶向性和治疗乳腺癌的抗肿瘤功效:最新研究进展综述。
Curr Pharm Des. 2020;26(42):5365-5379. doi: 10.2174/1381612826666200721000958.

引用本文的文献

1
OSW-1 inhibits tumor cell proliferation and migration via uncoupling protein 2 in hepatocellular carcinoma.OSW-1通过肝细胞癌中的解偶联蛋白2抑制肿瘤细胞增殖和迁移。
Oncol Lett. 2025 May 22;30(1):361. doi: 10.3892/ol.2025.15107. eCollection 2025 Jul.

本文引用的文献

1
Berberine encapsulated phenylboronic acid-conjugated pullulan nanoparticles: Synthesis, characterization and anticancer activity validated in A431 skin cancer cells and 3D spheroids.黄连素包封的苯硼酸偶联普鲁兰纳米粒的合成、表征及在 A431 皮肤癌细胞和 3D 球体中的抗癌活性验证。
Int J Biol Macromol. 2024 Jul;273(Pt 1):132737. doi: 10.1016/j.ijbiomac.2024.132737. Epub 2024 May 31.
2
Combinatorial Therapy: Targeting CD133+ Glioma Stem-like Cells with a Polysaccharide-Prodrug Complex Functionalised Gold Nanocages.联合疗法:用多糖-前药复合物功能化金纳米笼靶向CD133+胶质瘤干细胞样细胞
Biomedicines. 2024 Apr 23;12(5):934. doi: 10.3390/biomedicines12050934.
3
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
4
Cytotoxic and epigenetic effects of berberine-loaded chitosan/pectin nanoparticles on AGS gastric cancer cells: Role of the miR-185-5p/KLF7 axis, DNMTs, and global DNA methylation.载小檗碱壳聚糖/果胶纳米粒对 AGS 胃癌细胞的细胞毒性和表观遗传作用:miR-185-5p/KLF7 轴、DNMTs 和全基因组 DNA 甲基化的作用。
Int J Biol Macromol. 2024 Mar;260(Pt 2):129618. doi: 10.1016/j.ijbiomac.2024.129618. Epub 2024 Jan 20.
5
Natural ursolic acid based self-therapeutic polymer as nanocarrier to deliver natural resveratrol for natural therapy of acute kidney injury.基于天然熊果酸的自治疗聚合物作为纳米载体递送天然白藜芦醇用于急性肾损伤的自然疗法。
J Nanobiotechnology. 2023 Dec 17;21(1):484. doi: 10.1186/s12951-023-02254-x.
6
Collagen-Binding Nanoparticles for Paclitaxel Encapsulation and Breast Cancer Treatment.胶原结合纳米粒子用于紫杉醇包封和乳腺癌治疗。
ACS Biomater Sci Eng. 2023 Dec 11;9(12):6805-6820. doi: 10.1021/acsbiomaterials.3c01332. Epub 2023 Nov 20.
7
Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy.载有卡培他滨的前药纳米颗粒通过调节肠道微生物群和化疗来改善结直肠癌治疗。
Nat Commun. 2023 Aug 7;14(1):4746. doi: 10.1038/s41467-023-40439-y.
8
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics.癌症化疗及其他:当前状况、候选药物、相关风险以及靶向治疗的进展。
Genes Dis. 2022 Mar 18;10(4):1367-1401. doi: 10.1016/j.gendis.2022.02.007. eCollection 2023 Jul.
9
Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery.用于抗癌药物递送的基于透明质酸的纳米载体
Polymers (Basel). 2023 May 16;15(10):2317. doi: 10.3390/polym15102317.
10
Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel.与萜类生物碱(紫杉醇、多西他赛和卡巴他赛)临床应用相关的化疗特性及副作用。
Front Pharmacol. 2023 May 9;14:1157306. doi: 10.3389/fphar.2023.1157306. eCollection 2023.